The Therapeutic Goods Administration (TGA) has issued 12 infringement notices totalling $126,720 to 2 companies and 5 individuals for alleged ...

LTR Pharma Reports Real-World Findings for Intranasal Erectile Dysfunction Spray; Shares Jump 12% MT Jul. 16 LTR Pharma Executes Definitive US Distribution Agreement With Shed Holdings for ROXUS, ...

The milestone marks the start of ROXUS prescription activity through telehealth and pharmacy arrangements established under LTR Pharma’s (ASX:LTP) agreements ... Read More The post First US ...

On November 17, investors in aged care and retirement operator Regis Healthcare (ASX:REG) should hear an update on cost-cutting efforts. Management may also announce a delay to some of the company’s ...

A blood test that can cheaply detect the disease. Promising new treatments. These developments are game changers.

There is one simple question that I rarely hear asked outright: How long should I be able to last in bed? It's more ...

Grindr just spent $250 million to become a healthcare company. Here's what that means for its 15 million users.

These simple snacks taste great and support a healthy liver.

THE shape of your penis isn’t just the way you are – it can actually tell you a lot about your health. From heart issues to ...

Today, men's health platform Mavrox, announced the launch of Roxus®, an intranasal delivery for erectile dysfunction. By bypassing hepatic first-pass metabolism, Roxus® acts faster at a lower dose ...

The Miami Beach practice now uses quantified stem cell and extracellular vesicle products, along with an autologous option ...

Through BIO REBOOT, individuals and teams can bring research questions, technical expertise and drug discovery ideas to the PDAOAI community. Registration is free at Selected projects may be ...